There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Pharming Group (PHAR – Research Report), SurModics (SRDX – Research Report) and REPRO-MED Systems (KRMD – Research Report) with bullish sentiments.
Pharming Group (PHAR)
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Pharming Group today and set a price target of $37.00. The company’s shares closed last Thursday at $12.00.
According to TipRanks.com, Pantginis is a 3-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Pharming Group with a $37.00 average price target.
See today’s best-performing stocks on TipRanks >>
SurModics (SRDX)
Barrington analyst Michael Petusky maintained a Buy rating on SurModics today and set a price target of $69.00. The company’s shares closed last Wednesday at $32.60.
According to TipRanks.com, Petusky is a 5-star analyst with an average return of
Currently, the analyst consensus on SurModics is a Moderate Buy with an average price target of $52.50.
REPRO-MED Systems (KRMD)
In a report released today, Alexander Nowak from Craig-Hallum maintained a Buy rating on REPRO-MED Systems, with a price target of $6.00. The company’s shares closed last Wednesday at $2.48, close to its 52-week low of $2.13.
According to TipRanks.com, Nowak is a 4-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for REPRO-MED Systems with a $5.25 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on PHAR:
